Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Yield stocks
Momentum stocks
Trend-Following Stocks
Undervalued stocks
Growth stocks
ESG stocks
Investment Themes
Hydrogen
Sin stocks
Strategic Metals
Education
Place your bets
The SPAC
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Financial Data
Europe's family businesses
Fintechs
Artificial Intelligence
US Basketball
Sin stocks
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
Switzerland
Swiss Exchange
IGEA Pharma N.V.
News
All News
IGPH
NL0012768675
IGEA PHARMA N.V.
(IGPH)
Add to my list
Report
Delayed Swiss Exchange -
11:30 2022-07-04 am EDT
0.1085
CHF
-1.36%
06/26
IGEA PHARMA N
: Notice to postpone annual general meeting IGEA Pharma N.V.
PU
06/15
IGEA PHARMA N
: Note of the Board
PU
06/15
IGEA PHARMA N.V.
: IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Other languages
Press Releases
Official Publications
Sector news
All news about IGEA PHARMA N.V.
06/26
IGEA PHARMA N
: Notice to postpone annual general meeting IGEA Pharma N.V.
PU
06/15
IGEA PHARMA N
: Note of the Board
PU
06/15
IGEA PHARMA N.V.
: IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
06/08
Igea Pharma Secures $6 Million Funds To Complete Cannabidiol Extraction Facility
MT
06/07
IGEA PHARMA N.V.
: Igea pharma has signed a preliminary agreement with lmh-an industrial h..
EQ
05/02
IGEA Pharma Gets Swiss Bourse Approval To Delay FY21 Annual Report Publication
MT
05/02
IGEA PHARMA N.V.
: IGEA to get SIX approval to delay the 2021 annual report disclosure
EQ
05/01
IGEA PHARMA N
: to get SIX approval to delay the 2021 annual report disclosure
PU
02/01
IGEA PHARMA N
: non-executive board members resigned after completion of the first post-co..
PU
2021
IGEA PHARMA N
: GBC Research report IGEA Pharma N.V.
PU
2021
IGEA PHARMA N
: GBC AG Publishes initial equity research report with buy recommendation an..
PU
2021
IGEA PHARMA N.V.
: Gbc ag publishes initial equity research report with buy recommendation..
EQ
2021
IGEA PHARMA N
: GBC AG to start equity coverage of IGEA Pharma
PU
2021
IGEA PHARMA N
: H1 Loss Narrows on Gains From Financial Liabilities, Sale of Assets
MT
2021
IGEA Pharma N.V. Reports Earnings Results for First Half 2021
CI
2021
Igea Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021
IGEA PHARMA N
: discloses its half-2021 financials
PU
2021
IGEA PHARMA N
: has been granted the listing of the new shares from SIX Exchange Regulatio..
PU
2021
IGEA PHARMA N
: to submit the listing prospectus to the SIX following the business combina..
PU
2021
IGEA PHARMA N
: to boost revenues entering the growing cannabis market
PU
2021
IGEA PHARMA N
: Expects Earnings, Revenue Boost On Blue Sky Natural Resources Deal
MT
2021
IGEA PHARMA N
: Declares All-Equity Offer for Blue Sky Natural Resources Unconditional
MT
2021
IGEA PHARMA N
: Minutes of the AGM 9 July 2021 + Attendance list
PU
2021
IGEA PHARMA N
: announces Annual General Meeting resolutions
PU
2021
IGEA PHARMA N
: Launches All-Equity Offer To Buy Blue Sky Natural Resources
MT
2021
IGEA PHARMA N
: To launch the all equity offer to blue sky natural resources ltd.
EQ
2021
IGEA PHARMA N
: Convening notice and agenda
PU
2021
IGEA PHARMA N
: Names New Chair
MT
2021
IGEA PHARMA N
: announces changes in its board and other corporate updates
EQ
2021
IGEA Pharma N.V. Announces Executive Changes
CI
2021
IGEA PHARMA N
: announces changes in its board and other corporate updates
PU
2021
IGEA PHARMA N
: disclosed its Annual Report 2020
EQ
2021
IGEA PHARMA
: Annual report
PU
2021
IGEA PHARMA N
: disclosed its Annual Report 2020
PU
2021
IGEA PHARMA N
: Secures $12 Million Investment From Negma
MT
2021
IGEA Pharma N.V. Reports Unaudited Earnings Results for the Year 2020
CI
2021
IGEA PHARMA N
: to get SIX approval to delay the 2020 annual report disclosure
EQ
2021
IGEA PHARMA N
: to get SIX approval to delay the 2020 annual report disclosure
PU
2021
IGEA PHARMA N
: announces extraordinary general meeting results
EQ
2021
IGEA PHARMA N
: announces extraordinary general meeting results
PU
2021
IGEA PHARMA N
: Minutes of the EGM 28 April 2021
PU
2021
IGEA Pharma Strikes Two-Year Convertible Bond Deal With Negma
MT
2021
IGEA PHARMA N
: to secure convertible bond commitment with Negma Group
PU
2021
IGEA PHARMA N
: to secure convertible bond commitment with Negma Group
EQ
2021
IGEA PHARMA N
: CFO Resigns, Interim Successor Appointed
MT
2021
IGEA Pharma N.V. Announces Termination of Patrick Pozzorini as CFO
CI
2021
IGEA PHARMA N
: and its CFO end collaboration
EQ
2021
IGEA PHARMA N
: and its CFO end collaboration
PU
2021
IGEA PHARMA N
: Convening notice
PU
2021
IGEA PHARMA N
: to finalize on convertible bond facility arrangement
PU
2021
IGEA Pharma N.V. announced that it expects to receive €10 million in funding from Negma..
CI
2021
IGEA PHARMA N
: calls extraordinary general meeting
PU
2021
IGEA PHARMA N
: announces three new board members
EQ
2021
IGEA PHARMA N
: announces three new board members
PU
2021
IGEA Pharma N.V. Announces Three New Board Members
CI
2021
IGEA PHARMA N
: calls extraordinary general meeting
EQ
2021
IGEA PHARMA N
: announces changes in its board
PU
2021
IGEA PHARMA N
: announces changes in its board
EQ
2021
IGEA Pharma N.V. Announces Resignation of Mr. Camillo Ricordi and Mr. Barth Armand Gree..
CI
2021
IGEA PHARMA N
: to Close Blue Sky Natural Resources Merger in April
MT
2021
IGEA PHARMA N
: to update on business combination
EQ
2020
IGEA Pharma N.V. Announces Signature of an Agreement with CSM Europe for the CE Complia..
CI
2020
IGEA PHARMA N
: ensures ‘Alz1' supply for the EU market
PU
2020
IGEA Pharma N.V. cancelled the acquisition of 66% stake in Meditalia Srl from from cert..
CI
2020
IGEA PHARMA N
: announces changes in its board
EQ
2020
IGEA Pharma N.V. Announces Resignation of Mark De Simone from the Board of Directors
CI
2020
IGEA PHARMA N
: discloses its half-2020 financials
EQ
2020
IGEA Pharma N.V. Reports Group Earnings Results for the First Half Ended June 30, 2020
CI
2020
IGEA PHARMA N
: discloses its half-2020 financials
PU
2020
Blue Sky Natural Resources Ltd signed letter of intent to acquire IGEA Pharma N.V. in a..
CI
2020
IGEA PHARMA N
: and Blue Sky Natural Resources to combine businesses
EQ
2020
IGEA PHARMA N
: announces changes in its board
EQ
2020
IGEA Pharma N.V. Announces the Resignation of Marco Seniga from its Board of Directors
CI
2020
IGEA PHARMA N
: announces changes in its board
PU
2020
IGEA PHARMA N
: announces annual general meeting resolutions
PU
1
2
Next
Upcoming sector events
07/29/22
DIASORIN S.P.A.
: Interim 2022 Earnings Release
08/03/22
10X GENOMICS, INC.
: Interim 2022 Earnings Release (Projected)
08/05/22
AUTOBIO DIAGNOSTICS CO., LTD.
: Interim 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances
Slave